{"id":"W4231682820","doi":"10.17925/use.2014.10.02.130","title":"The Future of Combination Therapies of Insulin with a Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes – Is it Advantageous?","year":2014,"lang":"en","type":"article","venue":"US Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Type 2 diabetes; Insulin; Combination therapy; Diabetes mellitus; Glucagon-like peptide 1 receptor; Internal medicine; Glucagon-like peptide-1; Endocrinology; Pharmacology; Receptor; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008919909,0.0001305901,0.0003194022,0.0001214377,0.00003613565,0.00000539962,0.0001116055,0.0000452155,0.00007254305],"category_scores_gemma":[0.00002561706,0.00008054038,0.0000427135,0.0001795738,0.0001725577,0.00003596639,0.0000466251,0.00009495572,0.00001952135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002995405,"about_ca_system_score_gemma":0.00002516497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002733289,"about_ca_topic_score_gemma":0.00009588145,"domain_scores_codex":[0.999126,0.00006558695,0.0002331356,0.000170861,0.0001343578,0.0002700287],"domain_scores_gemma":[0.9993163,0.0001125335,0.0001452077,0.0002982858,0.00010093,0.00002676386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009906829,0.0009585873,0.7324123,0.0003448939,0.0008903853,0.00001445356,0.002490959,0.000006448912,0.003956857,0.01895045,0.006823606,0.2321604],"study_design_scores_gemma":[0.008283591,0.005963162,0.2720557,0.0001974323,0.0002309724,0.000006384633,0.00190209,0.0001096045,0.02764417,0.00085039,0.6825212,0.0002352688],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901297,0.002312909,0.00000409301,0.004032191,0.0002773058,0.0003633746,0.000003460091,0.00001945859,0.002857494],"genre_scores_gemma":[0.9955143,0.002095578,0.0003322397,0.0004863378,0.00004264338,0.0000354586,0.00002706855,0.00001491456,0.001451429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6756976,"threshold_uncertainty_score":0.3284342,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007451804776659725,"score_gpt":0.2450223806573442,"score_spread":0.2375705758806845,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}